CLA pharma sector enquiry event

The IPKat has received notice of a forthcoming Competition Law Association event discussing the EU's Pharma Report.

'The Pharmaceutical Sector Inquiry: implications for the sector and beyond' will take place on 27 July at 6pm at the offices of Simmons & Simmons, CityPoint, One Ropemaker St, London EC2Y 9SS.

In the hotseat are Rowan Freeland (Simmons & Simmons) and Stephen Kon (SJ Berwin). The cost is £25 for non-members, £20 for members and £10 for associate members. CPD points are available.

If you're interested in going along send your name, address, any dietary requirement and an appropriate cheque to Sharon Horwitz, CLA Secretary, c/o Glynda Gabriel, Linklaters LLP, One Silk St, London EC2Y 8HQ.

STOP PRESS: this event will now take place a day earlier than originally publicised on 27 July. All other details remain the same.
CLA pharma sector enquiry event CLA pharma sector enquiry event Reviewed by Anonymous on Thursday, July 09, 2009 Rating: 5

No comments:

All comments must be moderated by a member of the IPKat team before they appear on the blog. Comments will not be allowed if the contravene the IPKat policy that readers' comments should not be obscene or defamatory; they should not consist of ad hominem attacks on members of the blog team or other comment-posters and they should make a constructive contribution to the discussion of the post on which they purport to comment.

It is also the IPKat policy that comments should not be made completely anonymously, and users should use a consistent name or pseudonym (which should not itself be defamatory or obscene, or that of another real person), either in the "identity" field, or at the beginning of the comment. Current practice is to, however, allow a limited number of comments that contravene this policy, provided that the comment has a high degree of relevance and the comment chain does not become too difficult to follow.

Learn more here:

Powered by Blogger.